Affordable automation of small clinical trials

By Kirsty Barnes

- Last updated on GMT

Related tags: Interactive voice response, Clinical trial, Covance

A new interactive voice response (IVR) package is available for
small clinical trials, aimed at companies who previously found this
technology unaffordable.

Covance has launched the new Express Suite of IVR services, designed for use in small, non-complex clinical trials and post-marketing studies, after spotting a gap in the market.

Traditionally, companies running small and simple clinical trials have laboured with error-prone and out-dated manual processes, as newer electronic data capture (EDC) and IVR technologies have been seen as too expensive, too complex and difficult to get off the ground.

"With the Express Suite, Covance is delivering the best of all worlds - a fast start-up, affordable, off-the-shelf solution, with the benefit of EDC, analysis, and reporting, all backed by Covance's extensive clinical expertise,"​ said Jim Denmark, general manager of Covance IVRS.

The Express Suite consists of several functionalities built in to serve the most common patient enrollment, randomisation, and drug supply management needs of biopharma firms sponsoring clinical studies, who have until now found automated methods unaffordable, said the company.

Suitable for studies with less than fifty investigator sites, up to five drug supply depots and a duration of two years, sponsors can use the system to view patient and drug supply activity and monitor progress, anticipate problems, and take preventive actions.

Because custom programming is not required, the implementation process is much faster than for custom-built systems, said the company.

Related news

Related products

RACE Act Prompts Pediatric Oncology Trials

RACE Act Prompts Pediatric Oncology Trials

PRA Health Sciences | 04-May-2020 | Technical / White Paper

Many providers prescribe drugs off-label to pediatric patients, even though there have been few pediatric trials for many of these drugs. In response,...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 01-Mar-2020 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

What do big pharma companies spend on R&D?

What do big pharma companies spend on R&D?

Zymewire | 15-Aug-2019 | Technical / White Paper

The free Big Pharma R&D Spend report examines the financial performance and research & development investments of the top 25 pharmaceutical companies...

Related suppliers

Follow us


View more